China Experts Give Hualan Second Thumbs Up To Make H1N1 Flu Vaccine
This article was originally published in PharmAsia News
Executive Summary
China's Hualan Biological Engineering has been recommended by a panel of experts to be cleared for producing a single-shot H1N1 flu vaccine. The State FDA is to decide on the recommendation later in the week and whether to give Hualan a license to produce the drug. One day earlier, the same panel recommended Sinovac Biotech to be cleared to launch a vaccine intended for people between the age of 3 years old and 60 years old. (Click here for more